What is NDC 69489-131?

69489-131 is the product NDC for Emrosi, Minocycline hydrochloride 40 mg/1 capsule, listed with the FDA by Journey Medical Corporation. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Emrosi (Minocycline Hydrochloride Extended-Release).

Journey Medical Corporation, NDC labeler code 69489. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Emrosi?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Emrosi NDC 69489-131 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69489-131Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69489-0131Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69489-131-07	69489013107	7 CAPSULE in 1 BOTTLE (69489-131-07)Marketed from Mar 10, 2025
69489-131-30	69489013130	30 CAPSULE in 1 BOTTLE (69489-131-30)Marketed from Mar 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Emrosi
Generic name (nonproprietary): minocycline hydrochloride extended-release
Active ingredients: Minocycline hydrochloride — 40 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Journey Medical CorporationNDC labeler code 69489
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 219015
Marketing start: Mar 1, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Prothrombin Activity (Physiologic effect)Tetracyclines (Chemical structure)
Identifiers: Product ID 69489-131_335d912c-9d84-1e78-e063-6294a90aa2f9SPL ID 335d912c-9d84-1e78-e063-6294a90aa2f9SPL set ID 0899eb25-8807-037c-f66c-141a2696b1c0RxCUI 2706371, 2706378UNII 0020414E5UUPC 0369489131071
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469489013107 followed by a unit qualifier and the quantity

Package 69489-0131-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 22, 2025.

Indications (excerpt from the label)

EMROSI is indicated to treat inflammatory lesions (papules and pustules) of rosacea in adults. Limitations of Use This formulation of minocycline has not been evaluated in the treatment or prevention of infections. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, use EMROSI only as indicated. EMROSI is a tetracycline-class drug indicated to treat inflammatory lesions (papules and pustules) of rosacea in adults. ( 1 ) Limitations of Use This formulation of minocycline has not been evaluated in the treatment or prevention of infections. To reduce the development of drug-resistant bacteria and to maintain the effectivene…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69489-131

What is NDC 69489-131?: 69489-131 is the product NDC for Emrosi, Minocycline hydrochloride 40 mg/1 capsule, listed with the FDA by Journey Medical Corporation. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Emrosi (Minocycline Hydrochloride Extended-Release).
What is the active ingredient?: Minocycline hydrochloride.
Who is the labeler?: Journey Medical Corporation, NDC labeler code 69489. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Emrosi?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.